Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy

Epilepsy and Behavior

Volumn 45, Issue , 2015, Pages 49-52

  Press, Craig A ^a   Knupp, Kelly G ^a   Chapman, Kevin E ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antiepileptic drugs; Cannabidiol; Cohort studies; Epilepsy; Medical marijuana; Pediatric

Indexed keywords

ANTICONVULSIVE AGENT; CANNABIS; DRUG THERAPY; ORAL CANNABIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ABNORMAL MOVEMENT; ADOLESCENT; ADULT; ALERTNESS; ANTICONVULSANT THERAPY; ANXIETY; ARTICLE; BEHAVIOR; BRAIN CORTEX ATROPHY; CHILD; CHOLECYSTITIS; DEATH; DEVELOPMENTAL REGRESSION; DISEASE CONTROL; DRUG INDUCED DISEASE; DRUG RESISTANT EPILEPSY; DRUG THERAPY; ELECTROENCEPHALOGRAM; EPILEPSIES, MYOCLONIC; EPILEPSY; EPILEPTIC STATE; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; INSOMNIA; INTUBATION; IRRITABILITY; LANGUAGE ABILITY; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE HYPOTONIA; MYOCLONIC ASTATIC EPILEPSY; OPISTHOTONUS; PARENT; PEDIATRICS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SEIZURE; SEIZURES; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SOMNOLENCE; TERTIARY CARE CENTER; TRANSIENT HEMIPARESIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTICONVULSANTS; CANNABIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANT EPILEPSY; DRUG THERAPY; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; INFANT; LENNOX GASTAUT SYNDROME; MALE; PARENTS; PLANT EXTRACTS; RETROSPECTIVE STUDIES; SEIZURES; THERAPEUTIC USE; TREATMENT OUTCOME;

EID: 84964227461     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.02.043     Document Type: Article

References (15)

1. (CDC) Centers for Disease Control and Prevention Epilepsy in adults and access to care-United States, 2010. Morbidity and mortality weekly report 2012, 61:909-913. MMWR.
2. Gloss D., Vickrey B. Cannabinoids for epilepsy. Cochrane Database Syst Rev 2012, 6:CD009270.
3. Porter B.E., Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 2013, 29:574-577.
4. Honarmand K., Tierney M.C., O'Connor P., Feinstein A. Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology 2011, 76:1153-1160.
5. Pavisian B., MacIntosh B.J., Szilagyi G., Staines R.W., O'Connor P., Feinstein A. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study. Neurology 2014, 82:1879-1887.
6. Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia 2010, 51:7-26.
7. Elger C., Halász P., Maia J., Almeida L., Soares-da-Silva P., Group B-IS Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 2009, 50:454-463.
8. French J.A., Krauss G.L., Biton V., Squillacote D., Yang H., Laurenza A., et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 2012, 79:589-596.
9. Ng Y.T., Conry J.A., Drummond R., Stolle J., Weinberg M.A., Investigators O.-S. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011, 77:1473-1481.
10. Porter R.J., Burdette D.E., Gil-Nagel A., Hall S.T., White R., Shaikh S., et al. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials. Epilepsy Res 2012, 101:103-112.
11. Chervin R.D., Ruzicka D.L., Giordani B.J., Weatherly R.A., Dillon J.E., Hodges E.K., et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 2006, 117:e769-e778.
12. Carlini E.A., Cunha J.M. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 1981, 21:417S-427S.
13. Murillo-Rodríguez E., Millán-Aldaco D., Palomero-Rivero M., Mechoulam R., Drucker-Colín R. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett 2006, 580:4337-4345.
14. Nicholson A.N., Turner C., Stone B.M., Robson P.J. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004, 24:305-313.
15. Russo E.B., Guy G.W., Robson P.J. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 2007, 4:1729-1743.